LUCAS DVORCHAK: Open Payments
NPI 1598050502 · WEIRTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 26 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 7 | $212 |
| GENZYME CORPORATION | 3 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Organon LLC | 3 | $35 |
| Galderma Laboratories, L.P. | 2 | $35 |
| Janssen Biotech, Inc. | 2 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $27 |
| Lilly USA, LLC | 1 | $20 |
| Amgen Inc. | 1 | $18 |
Products named: Bimzelx, DUPIXENT, Rhapsido, NEMLUVIO, TREMFYA, Winlevi, TALTZ, OTEZLA.
Industry payments across WV — which companies pay providers there.
